<div>When our beautiful little boy Lowie arrived into the world, little did we know of the challenges that would lie ahead for him.
</div>
<div><br />
</div>
<div>After a healthy pregnancy and straightforward delivery, he seemed very sleepy, had trouble feeding, slow weight gain, and later didn’t meet his motor milestones as expected. We became increasingly concerned and referred to a range of professionals. Lowie finally walked at 26 months, at which point we breathed a sigh of relief. Unfortunately, this was short lived, as it became increasingly apparent to us that something with Lowie’s development was atypical, leading us to pursue further medical investigations.
</div>
<div><br />
</div>
<div>We found out in November 2024, the day before Lowie’s third birthday, that he has CTNNB1 syndrome. CTNNB1 is a rare genetic condition which impacts the function of a protein in the brain called beta-catenin. It is a de novo mutation, which means it is a genetic alteration that appears for the first time in a family, meaning it wasn't inherited from either parent.
</div>
<div>It affects brain growth and development and therefore causes issues with Lowie’s movement and mobility, learning and cognitive development, sensory processing, speech, language and communication skills. Ultimately, life for Lowie could look very different to what we had hoped for him. 
</div>
<div><br />
</div>
<div>Lowie is known to various departments at Great Ormond Street Hospital for Children and he has been so brave throughout many appointments and investigations. Lowie also has speech and language therapy, occupational therapy, physiotherapy, music therapy, conductive education, with a number of these therapies privately funded, and is known to a variety of local health services. 
</div>
<div><br />
</div>
<div>After the diagnosis and an initial flurry of research and activity, including a contact with Špela Miroševič, President of the CTNNB1 Foundation, we felt a mixture of emotions; anger, anxiety, sadness, grief, despair, with a little hope sprinkled in, knowing that a Gene Replacement Therapy programme was in advanced stages. This all came at a difficult time, during the ill health of our beloved mum and grandmother, Marian, who recently passed in July 2025.
</div>
<div><br />
</div>
<div>In June 2025, our family went to Bilbao for the 3rd International CTNNB1 conference and we realised that hope for Lowie is closer than we expected.
</div>
<div><br />
</div>
<div>The CTNNB1 Foundation has submitted the clinical trial submission paperwork for Gene Replacement Therapy. The CTNNB1 Foundation was established on February 5, 2021, less than a year after the Foundation President’s son was diagnosed with CTNNB1 syndrome. CTNNB1 Foundation is a non-profit organisation whose central purpose is to improve the lives of children diagnosed with life-threatening and life-limiting rare genetic mutations. These, sometimes called orphan diseases, are simply not common enough to motivate 'for profit' pharmaceutical companies to investigate further. In the end, it is usually the parents who fight alone to develop treatment solutions. We are in awe of the work that the CTNNB1 Foundation have undertaken to make the prospect of Gene Replacement Therapy possible, and we want to contribute to these efforts in any way we can.
</div>
<div><br />
</div>
<div>We have decided to start this GoFund Me page as a way of supporting Lowie and other children to receive treatment. We are in the process of registering a UK charity, so that we can help with fundraising on a larger scale, make a financial contribution from the UK to the international efforts, raise awareness of CTNNB1 amongst the community and also support other UK families who have children with the condition.
</div>
<div><br />
</div>
<div>The foundation needs to raise around £445,000 of further funding in order for the clinical trial to begin later this year (2025). Much of the funding so far has come from the individual efforts of families, as well as some overseas government and corporate donations. After the first phase of the clinical trial, there will be subsequent phases, and if efficacy and safety is met, that is when the treatment will potentially be marketable, hence the clinical trials are the next step in this journey.
</div>
<div><br />
</div>
<div>Please give whatever you can and share as widely as you can. Send it to your friends, colleagues, neighbours, employers, and contact us if you have any ideas about how we can raise funds.
</div>
<div><br />
</div>
<div>We can’t do this alone, but, together, it may be possible. ❤️
</div>
<div><br />
</div>
<div><br />
</div>

Luke Coulthard

siobhan mcpaul

Tricia Aldred

Gemma Aukett

Louise Hutchings

Julie Carden

Nicole Horgan

Lisa Giles

Kieran Knowles

Emma Rance

Rosie Maxwell

Catherine Johnson

Michael O’Sullivan

Anonymous

Helen Ricardo

Laura Rowlands

Hannah Smith

Emily Bianchi

Lovely Little Lowie- fundraising for CTNNB1 gene therapy

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

currencyCode

Money Box Donation List Prompt Experiment Audience

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

Eligible for Profile Share Badge

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

NPO upsell education category

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

NPO recommendations prod

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

isEligibleForProfileBadge

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

categoryGroup

isCampaignOwner

fundHasInstagramDeepLink

Native 11.3.0 and above

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

NPO upsell animals category

NPO upsell disaster relief category

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

NPO upsell essential needs category

NPO upsell medical category

userCurrencyCode

Localized Currency

NPO upsell cancer category

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Lovely Little Lowie- fundraising for CTNNB1 gene therapy

Still £47,397 to go. Help us build momentum.